Understanding the molecular basis and consequences of chemoradiosensitivity in rectal cancer in order to improve tharapy (MOL-RSRC)

Medicine & Life Sciences

1. Retroperitoneal liposarcoma 100%
2. SARS Virus 88%
3. Coronavirus Infections 86%
4. Colorectal Neoplasms 81%
5. Organoids 79%
6. Severe Acute Respiratory Syndrome 77%
7. Fecal Microbiota Transplantation 74%
8. Whole Genome Sequencing 64%
9. Neoplasms 63%
10. Ulcerative Colitis 59%
11. Tumor Burden 57%
12. Nanopore Sequencing 54%
13. Military Facilities 47%
14. Tissue Donors 47%
15. High-Throughput Nucleotide Sequencing 45%
16. Coronavirus 45%
17. Tetraspanins 44%
18. Circulating Tumor DNA 43%
19. Methylation 42%
20. Gene Fusion 39%
21. Afghanistan 39%
22. Fragile X Syndrome 39%
23. Liposarcoma 38%
24. Sclerosing Cholangitis 38%
25. Iraq 37%
26. Neurosurgeons 35%
27. Machine Learning 34%
28. Seroepidemiologic Studies 33%
29. Gastrointestinal Microbiome 33%
30. Bile Acids and Salts 31%
31. Genome 30%
32. Rectal Neoplasms 30%
33. Mutation 30%
34. Genomics 30%
35. Phosphatidylinositol 3-Kinases 29%
36. Traumatic Brain Injury 29%
37. Inflammatory Bowel Diseases 28%
38. Population 28%
39. Health Personnel 26%
40. Biomarkers 26%
41. Cytoreduction Surgical Procedures 26%
42. RNA Sequence Analysis 24%
43. Genes 24%
44. Emergencies 23%
45. Carcinogenesis 23%
46. Transplantation 23%
47. RNA 22%
48. DNA 22%
49. Extremities 22%
50. Systematic Reviews 22%
51. Therapeutics 22%
52. Genotype 21%
53. Survival 21%
54. Pleasure 21%
55. Gene Expression 21%
56. Single Nucleotide Polymorphism 20%
57. Cross-Sectional Studies 19%
58. Radiotherapy 19%
59. Neoplasm Metastasis 18%
60. Equipment and Supplies 18%
61. Drug Therapy 17%
62. Up-Regulation 17%
63. Stereotyped Behavior 16%
64. Nucleotides 16%
65. Clinical Trials 15%
66. Saliva 14%
67. Programmed Cell Death 1 Receptor 14%
68. ErbB Receptors 14%
69. Epigenomics 14%
70. Monoamine Oxidase 14%
71. Chromosomes, Human, Pair 12 13%
72. Chromosomes, Human, Pair 6 13%
73. Chemoradiotherapy 12%
74. Cetuximab 12%
75. Microsatellite Instability 12%
76. Formaldehyde 12%
77. Immunity 11%
78. Technology 11%
79. Transcriptome 11%
80. Ireland 11%
81. Cell Line 11%
82. Metabolomics 11%
83. Dopamine 10%
84. Microbiota 9%
85. Hospital Departments 9%
86. DNA Repair 9%
87. Radiation 9%
88. Syntenins 8%
89. Incidence 8%
90. Immunotherapy 8%
91. Patient Selection 8%
92. Bacteroides 8%
93. Compulsive Behavior 8%
94. Exons 8%
95. Drug Repositioning 8%
96. Occupational Groups 7%
97. Hypoxia 7%
98. HCT116 Cells 7%
99. Nanopores 7%
100. Semantic Web 7%
101. Mechanistic Target of Rapamycin Complex 1 7%
102. Critical Care 7%
103. Sensitivity and Specificity 7%
104. Self-Injurious Behavior 7%
105. Population Biological Variation 7%
106. Antibodies 7%
107. Neurodevelopmental Disorders 7%
108. Clustered Regularly Interspaced Short Palindromic Repeats 6%
109. University Hospitals 6%
110. Delivery of Health Care 6%
111. Genetic Association Studies 6%
112. Intelligence 6%
113. Pathology 6%
114. Genome-Wide Association Study 6%
115. Aggression 6%
116. Epithelial-Mesenchymal Transition 6%
117. Attention Deficit Disorder with Hyperactivity 6%
118. Asymptomatic Infections 6%
119. Autistic Disorder 6%
120. Extracellular Vesicles 5%
121. Genetic Variation 5%
122. Housekeeping 5%
123. Clostridiales 5%
124. Gene Regulatory Networks 5%
125. Lung 5%
126. Pandemics 5%
127. Social Media 5%
128. Registries 5%
129. Reading 5%
130. Serotonin 5%
131. RNA-Directed DNA Polymerase 5%